The Future of Pharma: AI in Drug Research, Quality & Regulatory Affairs

Join us to discuss the role of AI in Drug Research, Quality & Regulatory Affairs

Artificial Intelligence is revolutionizing the pharmaceutical industry—accelerating drug discovery, optimizing quality assurance, and reshaping regulatory processes.

This event, co-organised by The French Chamber of Commerce, The Singaporean-German Chamber of Industry and Commerce and Life Science Incubator, will bring together experts across R&D, manufacturing, and regulatory affairs to explore how AI is being used to drive innovation, ensure compliance, and improve patient outcomes.

Key topics will include:

• AI in Drug Discovery
  How AI helps find drug targets, predict outcomes, and improve clinical trials

• AI in Manufacturing & Quality
  Using AI for real-time monitoring, automated checks, and better processes

• AI in Regulatory Affairs
  Understanding how AI fits into regulations and helps prepare for audits

• Data & AI Governance
  Making sure data is reliable, models are validated, and AI is used ethically

• Real-World Examples & What's Next
  Case studies and how AI is shaping the future of personalized medicine

Whether you're in pharma, biotech, quality, or regulatory affairs, this event will offer actionable insights to help you leverage AI across the drug development lifecycle—safely, effectively, and compliantly.

Speakers

• Damien Keogh, Founder at BluMaiden Biosciences
• Karin Markgraf, Head of Regulatory Affairs Asia Pacific at Merck Group
• Maria Aileen Mabunay, Global Medical Lead at Sanofi

Moderator

• Maximilian Englisch, Global Vice-President of Sales at WALDNER Group

Event Location